Ado-trastuzumab emtansine Intravenous and Conjugated estrogens Intravenous
Determining the interaction of Ado-trastuzumab emtansine Intravenous and Conjugated estrogens Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ado-trastuzumab emtansine
Brand name: Kadcyla
Synonyms: Ado-trastuzumab emtansine, Ado-Trastuzumab Emtansine
Generic Name: conjugated estrogens
Brand name: Enjuvia, Premarin, Premarin Intravenous, Cenestin
Synonyms: Conjugated estrogens (Intravenous), Estrogens (Conjugated A/Synthetic), Conjugated estrogens
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ado-trastuzumab emtansine Intravenous-Conjugated estrogens synthetic a
- Ado-trastuzumab emtansine Intravenous-Conjugated estrogens synthetic b
- Ado-trastuzumab emtansine Intravenous-Conjugated Estrogens Tablets
- Ado-trastuzumab emtansine Intravenous-Conjugated estrogens vaginal
- Ado-trastuzumab emtansine Intravenous-Conray
- Ado-trastuzumab emtansine Intravenous-Conray 30
- Conjugated estrogens Intravenous-Adox Pak 2/100
- Conjugated estrogens Intravenous-Adoxa
- Conjugated estrogens Intravenous-Adoxa CK
- Conjugated estrogens Intravenous-Adoxa Pak
- Conjugated estrogens Intravenous-Adoxa Pak 1/100
- Conjugated estrogens Intravenous-Adoxa Pak 1/150